What has changed
The federal Department of Health, Disability and Ageing has made an amendment to the rules that set floor prices for certain brands of pharmaceutical items on the Pharmaceutical Benefits Scheme (PBS). The instrument is titled the National Health (Floor Price for Certain Brands of Pharmaceutical Items) Amendment Determination (No. 1) 2026.
The amendment adds additional designated brands to the existing 2023 floor price determination. The amendment was registered on 17 February 2026.
When it takes effect
The changes to designated brands take effect from 1 August 2026. The instrument is listed as no longer in force as of 1 August 2026, indicating it has been absorbed into the main determination from that date.
Nature of the change
This is a technical amendment to PBS pricing rules administered by the federal government. It does not replace the 2023 floor price determination but adds to it by expanding the list of designated brands covered by the floor price rules.
Key actions
- Check the full text of the amendment at https://www.legislation.gov.au/F2026N00130 to identify which specific brands have been added as designated brands under the floor price rules from 1 August 2026.
- Contact the Department of Health, Disability and Ageing directly for clarification on how the updated floor prices affect dispensing or pricing arrangements - the source does not provide a specific contact email or phone number for enquiries.
This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.